Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

Application to import GMO vaccine approved

MEDIA RELEASE

TUESDAY, APRIL 30, 2019

A genetically modified vaccine for the potentially deadly Japanese encephalitis virus (JEV) has been approved for importation and release into New Zealand, with its use subject to approval by Medsafe.
Manufacturer Sanofi SA applied to the Environmental Protection Authority (EPA) for approval to import and release the genetically modified, live-attenuated vaccine for JEV, called IMOJEV.

The EPA’s General Manager of Hazardous Substances and New Organisms, Dr Fiona Thomson-Carter, says “Japanese encephalitis is caused by a virus that is transmitted to humans by mosquitoes. This virus is not found in New Zealand.

“It’s important to note that IMOJEV can only be used in New Zealand with approval from Medsafe, and – if approved – the vaccine would be regulated by the requirements of the Medicines Act 1981, as a prescription-only medicine.”

According to the application, Sanofi intends to market and distribute the IMOJEV vaccine to healthcare providers in New Zealand mainly for the immunisation of travellers, including military personnel and emergency aid workers who are sent at short notice to regions where the virus is endemic.

The benefits of IMOJEV include that it is a single-dose vaccine and provides protection within three to seven days. The vaccine currently in use in New Zealand requires two doses, 28 days apart, in order to provide immunity.

The vaccine is approved in 16 other countries and jurisdictions, including Australia, and has an excellent environmental safety record.

Read the decision document

Background:
Japanese encephalitis virus is mostly found in Asia, but also occurs in northern Queensland and parts of the Western Pacific. It is endemic to 24 countries, but is not found in New Zealand.

There is no treatment available for Japanese encephalitis, and death rates can range from 10-20 percent.

ends

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Marsden Pipeline Rupture: Report Calls For Supply Improvements, Backs Digger Blame

The report makes several recommendations on how the sector can better prevent, prepare for, respond to, and recover from an incident. In particular, we consider it essential that government and industry work together to put in place and regularly practise sector-wide response plans, to improve the response to any future incident… More>>

ALSO:

Oil Scare: Trump Authorises Use Of Emergency Crude Stockpile

The New Zealand dollar fell against the US dollar after President Donald Trump authorised the use of the country's emergency crude stockpile after the weekend attack on Saudi Arabia’s major oil facilities. More>>

ALSO:

Pre-Post-Brexit Deal Talks: UK Trade Minister Visits Wellington

New Zealand should get a better deal for exports of sheepmeat, beef and dairy products into the United Kingdom after Brexit, the British Minister of State for Trade, Liz Truss, said in Wellington today. More>>

ALSO:

Not-Very Well: Tamarind Halts Tui Drilling; OMV Assesses Options

Tamarind Resources has halted drilling at its Tui oil field off the Taranaki coast after the first of the three planned wells came up dry. Managing director Ian Angell says that despite the “unexpected” result from the first well, the firm believes the other two prospects are worth pursuing. More>>

ALSO:

Seeking 'Clarity': Crown To Appeal Southern Response Decision, Offers Costs

“It is our intention that the clarity that will come from the outcome of these proceedings will enable the Crown to work with Southern Response to provide a soundly based proactive solution to those people that are affected.” More>>